Oncolytic Virus in Esophageal Squamous Cell Carcinoma

Conditions

• Esophageal Cancer

Interventions

• BIOLOGICAL: Oncolytic Virus: Administered via intratumoral injection (metastatic lesions in the neck or supraclavicular lymph nodes) once every 3 weeks, for a total of two to four doses.
• BIOLOGICAL: Oncolytic Virus: Administered via intratumoral injection (primary lesions) once every 3 weeks, for a total of two to four doses.

Sponsor

Sichuan University